Glass is commonly used as a packaging material due to its advantages such as impermeability, clarity, heat resistance allowing for sterilization, and inertness. The main types of glass used are soda lime glass and borosilicate glass. Glass manufacturing involves batching ingredients like silica, lime, and soda then melting, forming, annealing, sorting, and packaging. Forming methods include blow and blow and press and blow processes. Performance tests are conducted to ensure the quality and safety of glass packaging. Regulations govern the submission of data on glass packaging materials and components.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
content-
Glass
Properties of glass
Raw materials
Composition of glass
Manufacture of glass
Advantages
Disadvantages
Type of glass
Quality control tests for glasses
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
content-
Glass
Properties of glass
Raw materials
Composition of glass
Manufacture of glass
Advantages
Disadvantages
Type of glass
Quality control tests for glasses
After the manufacturing of the drug, it is essential that these should be stored properly. The stability of drug during it’s storage depend on so many factor and proper packaging is one of them. The pharmaceutical products are in direct contact with the container and closures. So improper packaging and poor quality of container may lead to deterioration of the product.
After the manufacturing of the drug, it is essential that these should be stored properly. The stability of drug during it’s storage depend on so many factor and proper packaging is one of them. The pharmaceutical products are in direct contact with the container and closures. So improper packaging and poor quality of container may lead to deterioration of the product.
A discussion on glass packaging materials, including composition and structure of glass, its physical properties, manufacturing, defect and design
Report in Food Packaging and Labelling
Quality control test for containers and closure Pratik Ghivepratikghive82
Quality control test for containers and closure Pratik Ghive covers all aspects in details in sample language with animated images of containers for better understanding
pharmaceutical packaging. lyophillized drugs packaging problems and their pro...Rahul Dubey
The pharmaceutical packaging specially focused on lyophillized drugs packaging. currently packaging systems and associated problems with current packaging system and there probable solutions.
This presentation contains an introduction to emerging healthcare Technologies. These emerging technologies include Data Analytics, AI, Blockchain, Telehealth, virtual reality, cloud computing, and IOT. The concept of Nanorobots as future medicine is also included in this presentation.
Introduction
Need of Nanosuspension
Advantages of Nanosuspension
Disadvantages of Nanosuspension
Method Of Preparation
Formulation Considerations
Characterization of Nanosuspension
Current Marketed Formulations
Pharmaceutical Applications
Introduction
Nanoparticle characterization techniques
Electron Microscope
Scanning electron microscope
Transmission electron Microscope
X-ray powder diffraction
Nuclear Magnetic Resonance
Introduction
Advantages & Disadvantages
Classification
Manufacturing of liposomes
Liposome characterization and control
Stability consideration for liposomal formulations
Regulatory science of liposome drug products
Drug release from liposomes
Applications
Recent innovations
Approved liposome products
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
This presentation contains
Introduction, Advantages & Disadvantages, Process of manufacturing, Evaluation and defects in Blister, strip & ALU ALU Packaging. Useful for pharmacy students to understand the concept of blister & strip packaging
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Light House Retreats: Plant Medicine Retreat Europe
Glass as Pharmaceutical packaging material
1. Glass as Packaging Material
Dr. Anil Pethe
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management,
SVKM’S NMIMS, Mumbai
2. • An amorphous inorganic product of fusion that has been cooled to a
rigid condition without crystallizing.
•Not a crystalline solid, not a liquid. It is a “frozen” liquid.
What is Glass?
3. • Type I Neutral (Borosilicate glass)
• Type II Treated Soda lime glass (surface treatment)
• Type III Soda lime glass
• Type IV NP Soda glass (Non-parenteral use)
Types of Glass?
5. • Impermeable to gases, odors, moisture and microorganisms
• Clarity, Transparency
• Because of high M.P. & heat resistance it can be sterilized by dry
or moist heat
• Most inert to all packaging materials
• It can be fabricated to produce variety of shapes
• Due to smooth surface, easy to clean
• Reusable & Recyclable
• Ideal for high speed filling lines
Advantages of Glass?
6. • Heavy
• Susceptible for mechanical breakage
• Unable to withstand sudden changes in temperature
• Leaching of Alkali
• Potential Hazards from glass splinters or fragments in food.
Disadvantages of Glass?
9. • It is just like Baking a cake i.e. all ingredients go in and they get mixed
together.
• This is the same for glass container mfg. as all the ingredients mixed
together, and put into shuttle device to bring the raw material to the
Furness.
Batching
10. • Melting of the ingredients occurs in the furnace, which turns the
contents into molten glass.
• This is the cooking process..
• Melting temperature 1550-1600°C
Melting
11. • Two common processes are used
• Blow & Blow process: In this parison is formed by compressed air.
The parison is then transferred into the mold to form specific
shape of the container.
• Press & Blow process: In this method parison I shaped by pressing
the glass against the blank mold with a metal plunger. The parison
is then transferred into the mold to form specific shape of the
container.
Forming
12. • Other processes
• Pressed Glassware: It involve first step of above process & the final
shape is achieved by one pressing of glass which is entrapped &
shaped between mould walls & plunger.
• Tubular Glassware: A tube of glass is first produced &
subsequently cut & shaped (after reheating) by separate process.
Forming
15. • Relatively recent process
• Similar to press & blow process
• More accurately control uniformity of glass distribution
• Weight is reduced upto 25%
Narrow Neck Press & Blow (NNPB)
16. • Slow cooling of the glass in order to strengthen the container.
• Produces a more stable product.
Annealing lehr
(oven) 540 oC
Holding for
15 minutes
Cooling
Almost the softening point
of glass
Annealing Process
17. • Heating to annealing point & then lowering the temp. gradually for
releasing the residual strain in the glass
• Controlled heating & cooling process designed to relieve internal
stress introduced in container during & immediately after glass
container formation.
• Annealing Point: The sp. Temp. in which internal stresses build up
during glass container formation.
Annealing Process
18. • Sorting is carried out either manual or automatic.
• To carryout automatic sorting operations the containers are put onto
a single line conveyer for electronic & mechanical checking i.e. body
dimensions, bore, visual damage etc.
• Manual testing is also performed at lab.
• The sorting area is usually screened from dirtier mfg. process & is
under positive pressure.
Sorting & Inspection
19. • Last part of the production process.
• Glass containers are supplied for many
years in open returnable wooden crates,
but currently used material:
• Fiber board outers
• Shrink wraps
• This is easy for Handling & Transportation.
Packaging
20. • The design involves two basic considerations
• Aesthetic appeal: Consumer convenience.
• Functional efficiency: on Production line, closuring, packing, warehousing &
finally stability at point of sale.
• Design which lead to point to point contact is susceptible to damage
so it should be avoided.
• Design provides a uniform wall section & avoid thick & thin areas.
Design
21. • Large flat surfaces should be avoided as these tend to sink during the
cooling & may give labeling & capacity problems.
• Height of the embossing should be kept minimum (0.4 – 0.75mm)
• A bottle must be designed to be removed from or clear the mould.
• The use of CAD/CAM & computer technology is widely applied to
improve the design
• Stippling of the base is useful in improving base grip, masking mould
scars & improving strength of the container.
Design
22. • Certain decorative process other than labeling
may be used.
• Ceramic Printing
• Thermo-Cal system
• Organic coating and inks
• Inorganic metallic oxide coating
• Colours imparted to Glass
Decoration
23. • Glass containers broadly divided into
• Narrow necked (including sprinkler)
• Wide necked
• Most specialized container names.
• Carboys: exist in balloon shape or cylindrical
or straight side form.
• Cylindrical rounds, Boston rounds: Convential
cylindrical bottle with near flat shoulders
• Winchesters: widely used in UK & covers range from
0.5fl.oz upwards.
Special Pharmaceutical Containers
25. • Limited use of these containers prior to 1917, but after
introduction of continuously drawing glass tube leads to
greater use.
• Advantages:
• Lower weight,
• Thinner & more even wall control
• Hermitically sealed
Tubular glass containers
26. • The current use of ampoule is vary static.
• It was one of the first unit dose container.
• Some std. are exist for ampoule shapes &
sizes with variations on the neck &
method of opening (scoring & ceramic
point)
• These are sterilized by dry heat or steam
after filling.
Ampoules
27. • These were popular in 1920s & 1930s when first
used.
• These are parallel side containers with a flat or
concave base with variety of neck finishes in various
capacities.
• Injection vials are obtained in either neutral or soda
glass & occasionally in treated soda glass.
• Rubber closure with aluminum over cap used
for multi-dose container
Vials
28. • Use of glass tube with an end cap seal & movable plunger is early
used for unit dose injectable in dental trade.
• The next stage was to combine cartridge tube and syringe thus
creating glass disposable syringe.
• These are also available with two compartments which allow unstable
parts of the pharmaceutical formulation to be kept separate and mix
immediately prior to use.
Disposable syringes
29. • Use of glass offers mixed comments on risk involved.
• Glass offers greater flexibility in design than metal cans.
• Breakage risk can be avoided by adequate bottle
strength plus an external coating of PVC
• Glass bottles cost more than metal cans but offer good
appearance.
• The valves are set in an aluminum over seal.
Aerosols
30. • Due to thermal shock or impact stress
• Can be grouped as:
Critical- hazardous to the user
Major- reduced usability of the container or its contents
Minor- usability of container not affected
• Can be classified as:
Checks
Seams
Non-glass inclusions
Dirt, dope, adhering particles or oil marks
Freaks and malformations
Marks
Glass Defects
33. • Thermal shock test
• Internal bursting pressure test
• Annealing test
• Vertical load test
• Leakage test
• Autoclaving
• Limit test for alkalinity or chemical resistance
Performance test applied to glass container
34. The samples are placed in an upright position in a tray which is immersed into hot
water for a given time, then transferred to a cold water bath.
Temperatures of both baths are closely controlled. Samples are examined before
and after the tests for outside surface cracks or breakage. The amount of thermal
shock a bottle will withstand depends on its size, design and glass distribution.
Small bottles will probably withstand a temperature differential of 60–80°C, and 1
pint bottles 30–40°C.
A typical test uses a 45°C temperature difference, hot to cold.
Thermal shock test
35. • The most common instrument is the American Glass Research
increment pressure tester.
• The test bottle is filled with water and then placed inside the test
chamber. A sealing head is applied and the internal pressure
automatically raised by a series of increments. Each increment is held
for a set time.
• The bottle can either be checked to a pre selected pressure level or
the test continued until the container finally bursts.
Internal bursting pressure test
36. • The sample is examined by polarised light in either a polariscope or a strain
viewer.
• The strain pattern is compared against standard strain discs or limit samples.
Normal annealed glassware shows limited strain patterns usually with
colours of red/blue—greater intensities of strain are indicated by colours
ranging from white/orange through red/purple to green, yellow and white.
• Both extremes indicate strain due to either tension or compression. The
interpretation of strain is frequently one of experience.
• When a glass bottle leaves a mould the outside tends to cool more rapidly
than the inside, leaving the inner surface under a state of tension. This strain
is normalised in the lehr, where the whole container is raised to dull red heat
and then cooled slowly.
Annealing test
37. • The bottle is placed between a fixed
platform and a hydraulic ramp platform
which is gradually raised so that a vertical
load is applied.
• The load is registered on a pressure gauge.
Vertical load test
38. • The Food D&C act places a requirement on the manufacturer to
submit data on packaging materials & components to FDA prior to
marketing.
• The same applies for pharmaceuticals under EU legislations.
• Submission must include data on all packaging material constituents
& adequate toxicological studies.
• In UK legislations are similar to USA involving various acts etc.
• Food Labeling Act
• Trade Description Act
• Weights & Measures Act
• The Poison Prevention Packaging Act
Legislations